Pharming Group NV(PHAR.US)

Last Updated 19:00:00 ET
longbridge loading

Pharming Group Balances Near-Term Strain With Joenja Growth

Tip Ranks·
US
PHAR
+2.14%
US
ARKG
+5.05%
US
SBIO
+3.75%
Tip Ranks·
US
PHAR
+2.14%
US
ARKG
+5.05%
US
SBIO
+3.75%

Pharming Group (OTCMKTS:PHGUF) Releases Quarterly Earnings Results

Market Beat·
US
PHAR
+2.14%
US
SBIO
+3.75%
US
IBBQ
+2.43%
Market Beat·
US
PHAR
+2.14%
US
SBIO
+3.75%
US
IBBQ
+2.43%

3 High-Risk, High-Reward Stocks to Buy Now for Explosive Upside, According to Analysts – 5/8/2026

Tip Ranks·
US
IVA
+4.68%
US
PHAR
+2.14%
US
ATAI
+3.28%
Tip Ranks·
US
IVA
+4.68%
US
PHAR
+2.14%
US
ATAI
+3.28%

Pharming Group (PHAR) Gets a Buy from Canaccord Genuity

Tip Ranks·
US
PHAR
+2.14%
US
IHE
+0.84%
Tip Ranks·
US
PHAR
+2.14%
US
IHE
+0.84%

Pharming To Present New Leniolisib Pediatric And CVID Data At CIS 2026

nasdaq·
US
PHAR
+2.14%
US
IBBQ
+2.43%
US
VHT
+0.27%
nasdaq·
US
PHAR
+2.14%
US
IBBQ
+2.43%
US
VHT
+0.27%

Pharming Group shares are trading lower after the company reported worse-than-expected Q1 financial results.

benzinga_article·
US
PHAR
+2.14%
US
IBBQ
+2.43%
US
IXJ
+0.35%
benzinga_article·
US
PHAR
+2.14%
US
IBBQ
+2.43%
US
IXJ
+0.35%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
TRDA
+6.90%
US
AGL
-8.23%
US
ATRA
+0.43%
benzinga_article·
US
TRDA
+6.90%
US
AGL
-8.23%
US
ATRA
+0.43%

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders | PHARM Stock News

StockTitan·
US
PHAR
+2.14%
US
IBB
+2.27%
US
XLV
-0.13%
StockTitan·
US
PHAR
+2.14%
US
IBB
+2.27%
US
XLV
-0.13%

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026 | PHARM Stock News

StockTitan·
US
PHAR
+2.14%
US
PBE
+1.60%
US
BIB
+4.98%
StockTitan·
US
PHAR
+2.14%
US
PBE
+1.60%
US
BIB
+4.98%
© 2026 Longbridge｜Disclaimer